| Health / Medical Topics |
Tyrosinase-KLH
A peptide vaccine containing a tyrosinase epitope conjugated with keyhole lymphocyte hemocyanin (KLH) with potential antineoplastic activity. Tyrosinase, one of the melanoma differentiation antigens, is the rate-limiting enzyme for melanin synthesis. This tyrosine epitope is conjugated with KLH, which serves as an immunostimulant and a hapten carrier, to enhance immune recognition. Vaccination with tyrosinase-KLH peptide vaccine may produce anti-tyrosinase antibodies as well as elicit a cytotoxic T lymphocyte (CTL) response against cells expressing tyrosinase antigen, resulting in decreased tumor growth. (NCI Thesaurus)
YOU MAY ALSO LIKE
A protein that is made from tumor cells and is used in a vaccine against melanoma. A tyrosinase peptide vaccine may stimulate…
Tyrosinase (529 aa, ~60 kDa) is encoded by the human TYR gene. This protein is involved in pigment biosynthesis, eye development and…
A tripeptide consisting of tyrosine, serine, and leucine with potential antineoplastic activity. Although the mechanism of its antitumor activity has yet to…
Human TYROBP wild-type allele is located in the vicinity of 19q13.1 and is approximately 4 kb in length. This allele, which encodes…
This gene plays a role in signal transduction for a variety of cellular processes.
Human TYRO3 wild-type allele is located within 15q15.1-q21.1 and is approximately 20 kb in length. This allele, which encodes tyrosine-protein kinase receptor…
